IL1B and lung carcinoma: IL-1β is a proinflammatory cytokine and has emerged as a therapeutic target for several inflammatory diseases, such as rheumatoid arthritis (29, 30); however, its role in the development of lung cancer, especially KM-LUAD, is not fully understood.